title: Clinical uses of intravenous immunoglobulin.
authors.affiliation: Department of Clinical Immunology, Royal Free Hospital London, UK. sjolles@nimr.mrc.ac.uk
authors.forename: S
authors.initials: S
authors.lastname: Jolles
authors.forename: W A C
authors.initials: WA
authors.lastname: Sewell
authors.forename: S A
authors.initials: SA
authors.lastname: Misbah
mesh_terms: D020274:Autoimmune Diseases of the Nervous System / Q000188:drug therapy / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology; D006402:Hematologic Diseases / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000276:immunology; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy / Q000276:immunology; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy / Q000276:immunology; D010392:Pemphigus / Q000188:drug therapy / Q000276:immunology; D011961:Receptors, Fc / Q000276:immunology; D018805:Sepsis / Q000276:immunology / Q000517:prevention & control; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy / Q000276:immunology
chemical_list: D007140:Immunoglobulin Fab Fragments; D016756:Immunoglobulins, Intravenous; D011961:Receptors, Fc; D003165:Complement System Proteins